Skip to main content
Premium Trial:

Request an Annual Quote

Luminex Licenses Cystic Fibrosis Biomarkers From Johns Hopkins

NEW YORK (GenomeWeb News) — Luminex has licensed from The Johns Hopkins University genetic markers that it plans to use with its Tag-It cystic fibrosis test kits.
Luminex said the tests are available through its Molecular Diagnostics division, which was formerly Tm Bioscience. Luminex bought and renamed Tm Bio in March.
The non-exclusive agreement enables the company to use the IP in kits sold in the US. The license cover four mutations — 549N, 551D, 553X, and 559T — tested in the kit and two mutations, 553X and 551D, that appear in the screening panel of 23 cystic fibrosis mutations recommended by the American College of Medical Genetics and the American College of Obstetrics and Gynecology.
Financial terms of the agreement were not released.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.